Dr. Peter Kayatz

Dr. Peter Kayatz

Dipl. Biologe, Dr. rer. nat., Dr. rer. medic.

Managing Director

Firma:
(sichtbar nur für registrierte Mitglieder)

6020 Innsbruck, Österreich

Dr. Peter Kayatz kontaktieren!

Melden sie sich kostenlos und unverbindlich beim Business-Netzwerk XING an.

Schon Mitglied? Einloggen und Dr. Peter Kayatz als Kontakt hinzufügen.

Berufserfahrung 

09/2008 - heute

(2 Monate)

09/2008 - heute

(2 Monate)

Shareholder / Gesellschafter

peakfactor GmbH, http://www.pharmapeak.com

Branche: Pharmazeutische Industrie, Science & business network for decision makers and professionals in the Pharma and Biotech Industry


09/2008 - 10/2008

(2 Monate)

Board Member

Axon Neurosciences Forschungs- und Entwicklungs GmbH, http://www.axon-neuroscience.at

Branche: Pharmazeutische Industrie, Developing therapeutic small molecules and vaccines for Alzheimer’s disease.

04/2004 - 05/2008

(4 Jahre, 2 Monate)

Managing Director

AlcaSynn Pharmaceuticals GmbH, http://www.alcasynn.com

Branche: Arzneimittel, Drug development company focusing on small molecules of the morphinan group. Lead Products in pain and immunomodulation.

04/2004 - 09/2004

(6 Monate)

10/2002 - 03/2004

(1 Jahr, 6 Monate)

Portfolio Manager

CAST Center vor Academic Spin-offs Tyrol GmbH, http://www.cast-tyrol.com

Branche: Unternehmensberatung, CAST is a technology transfer centre based at the University of Innsbruck, Tyrol, Austria. CAST offers management consulting and seed financing

02/2000 - 10/2002

(2 Jahre, 9 Monate)

Venture Capital Advisor

IVP Innovations & Venture Partners (now "Concentro"), http://www.ivp-venture.de

Branche: Unternehmensberatung, IVP - Innovations & Venture-Partners GmbH (www.ivp-venture.de) is a management consultancy, focussing on venture capital and private equity financing as well as turn-around management. Offered services are fund raising for high-tech companies, due diligence services for venture capital companies and interim management. In 2005 IVP Innovations & Venture Capital merged with FairVest forming Concentro Management (www.concentro.de).

10/2001 - 04/2002

(7 Monate)

Interim Manager

Innovatis AG, http://www.innovatis.com

Branche: Biotechnologie, developer, manufacturer and distributor of laboratory devices for automated cell culture analysis for the pharmaceutical and biotech industry.

1999 - 1999

Peer Reviewer

Graefes Arch Clin Exp Ophthalmol, http://www.springer.com/medicine/ophthalmology/journal/417

Branche: Journalismus, Graefe's Archive for Clinical and Experimental Ophthalmology Incorporating German Journal of Ophthalmology Editor-in-Chief: Bernd Kirchhof

Status
Unternehmer

Ausbildung

Hochschulen

University of Heidelberg, 2000 - 2001

Postgraduate 'BioBusiness'

Management of high-tech companies, accounting, financing & valuation, controlling, patenting & licensing

 

University of Heidelberg, 1999 - 1999

Postgraduate 'Medical Biometry'

Methods for the descriptive and analytical biostatistics and the interpretation thereof.

 

University of Cologne, Medical School, 1997 - 2000

Ophthalmology, Dr. rer. medic. - magna cum laude

Investigations regarding the pathogenesis of AMD (age related macular degeneration), with focus on the processing of peroxidized lipids and proteins in the retina of rats. A total of 11 scientific full papers. There of two first Author Papers in 'Invest Ophtalmol Vis Sci'

 

Technical University Aachen (RWTH), 1997 - 1999

Cell Biology, Dr. rer. nat. - summa cum laude / Borchers-Plakette

Development of the first electron microscopic technique for the ultra structural localization of lipid peroxides. Publication in 'Methods of Enzymology'

 

Diabetes Research Institute, Duesseldorf, 06/1994 - 07/1995

Diploma Thesis - Protein Chemistry, Diplom Biologe - summa cum laude

'Signal transduction of the insulin receptor – investigation of the autophosphorylation sites of the intra cellular domain of the insulin receptor'

 

University of Cologne, 1987 - 1994

University Degree in Biology, Diplom Biologe - summa cum laude

Advanced courses in biochemistry, molecular genetics, organic chemistry, botanic Grants by Bayer AG and Carl-Duisberg-Foundation

Sprachen
Deutsch, Englisch , Klartext

Über mich

Sind Sie schon dabei?

XING ist ein Business-Netzwerk für Geschäftsleute und verbindet Know-How mit Know-Who.

Nutzen Sie die Vorteile von XING:

  • Finden Sie neue Vertriebskanäle, Mitarbeiter und Jobs
  • Finden Sie Kollegen und Bekannte wieder
  • Erreichen Sie Experten per Mausklick

Suche im XING-Netzwerk

Finden Sie neue Business-Kontakte auf XING und treffen Sie alte Kontakte wieder!

Gruppen von Dr. Peter Kayatz: